pirfenidone has been researched along with prednisolone in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 5 (62.50) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Azuma, A | 1 |
Arimura, A; Hikita, I; Kawabata, T; Matsushima, S; Nagira, M; Oku, H; Shimizu, T; Torii, M; Ueyama, A | 1 |
Bajwah, S; Higginson, IJ; Koffman, J; Patel, AS; Peacock, JL; Riley, J; Ross, JR; Wells, AU | 1 |
Kunii, E; Moriyama, S; Niimi, A; Ohkubo, H | 1 |
Kamali, Y; Mandegary, A; Nabipour, F; Pourgholamhosein, F; Rasooli, R | 1 |
Homma, S; Kabuki, T; Shibuya, K; Sugino, K | 1 |
Behera, D; Deep, A; Gupta, S; Padhan, P; Priyadarshini, S; Singh, P | 1 |
2 review(s) available for pirfenidone and prednisolone
Article | Year |
---|---|
[Newly developed therapeutic drugs for idiopathic interstitial pneumonias].
Topics: Acetylcysteine; Drug Design; Drug Therapy, Combination; Humans; Interferon-gamma; Lung Diseases, Interstitial; Prednisolone; Pyridones; Randomized Controlled Trials as Topic | 2006 |
Interventions to improve symptoms and quality of life of patients with fibrotic interstitial lung disease: a systematic review of the literature.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Colchicine; Cough; Dyspnea; Exercise Test; Fibrosis; Glucocorticoids; Heroin; Humans; Immunologic Factors; Lung; Lung Diseases, Interstitial; Narcotics; Oxygen Inhalation Therapy; Piperazines; Prednisolone; Purines; Pyridones; Quality of Life; Sildenafil Citrate; Sulfones; Thalidomide; Tubulin Modulators | 2013 |
6 other study(ies) available for pirfenidone and prednisolone
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis.
Topics: Animals; Bleomycin; Chemokines; Cytokines; Dose-Response Relationship, Drug; Fibroblast Growth Factor 2; Intercellular Signaling Peptides and Proteins; Interferon-gamma; Interleukin-12 Subunit p40; Lung; Male; Mice; Mice, Inbred ICR; Prednisolone; Pulmonary Fibrosis; Pyridones; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha | 2008 |
Efficacy of combined corticosteroid and pirfenidone for acute exacerbation of idiopathic pulmonary fibrosis after surgery for lung cancer: a case report.
Topics: Acute-Phase Reaction; Aged, 80 and over; Disease Progression; Drug Therapy, Combination; Glucocorticoids; Humans; Idiopathic Pulmonary Fibrosis; Infusions, Intravenous; Lung Neoplasms; Male; Methylprednisolone; Postoperative Complications; Prednisolone; Pulse Therapy, Drug; Pyridones; Treatment Outcome | 2015 |
Combination Therapy with Pirfenidone plus Prednisolone Ameliorates Paraquat-Induced Pulmonary Fibrosis.
Topics: Animals; Anti-Inflammatory Agents; Cytoprotection; Disease Models, Animal; Drug Therapy, Combination; Gene Expression Regulation; Glucocorticoids; Hydroxyproline; Inflammation Mediators; Lung; Male; Matrix Metalloproteinase 2; Oxidative Stress; Paraquat; Prednisolone; Pulmonary Fibrosis; Pyridones; Rats, Sprague-Dawley; Tissue Inhibitor of Metalloproteinase-1; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha | 2018 |
Systemic scleroderma-related interstitial pneumonia associated with borderline pulmonary arterial hypertension.
Topics: Aged; Anti-Inflammatory Agents; Drug Therapy, Combination; Endothelin A Receptor Antagonists; Female; Humans; Hypertension, Pulmonary; Lung Diseases, Interstitial; Prednisolone; Pulmonary Artery; Pyridones; Pyrimidines; Scleroderma, Limited; Sulfonamides | 2018 |
Nintedanib vs pirfenidone in the management of COVID-19 lung fibrosis: A single-centre study.
Topics: Adult; C-Reactive Protein; COVID-19 Drug Treatment; Ferritins; Humans; Idiopathic Pulmonary Fibrosis; Indoles; Middle Aged; Prednisolone; Pyridones; Treatment Outcome | 2022 |